Corcept Therapeutics
CORT
#1995
Rank
NZ$17.61 B
Marketcap
NZ$164.13
Share price
4.46%
Change (1 day)
40.44%
Change (1 year)

Earnings for Corcept Therapeutics (CORT)

Earnings in 2026 (TTM): -NZ$17.01 Million

According to Corcept Therapeutics 's latest financial reports the company's current earnings are NZ$0.76 Billion. In 2025 the company made an earning of NZ$76.86 Million a decrease over its 2024 earnings that were of NZ$0.23 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Corcept Therapeutics from 2003 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -NZ$17.01 Million-122.13%
2025 NZ$76.86 M-67.29%
2024 NZ$0.23 B27.66%
2023 NZ$0.18 B-4.75%
2022 NZ$0.19 B-9.51%
2021 NZ$0.21 B-2.91%
2020 NZ$0.21 B14.87%
2019 NZ$0.19 B24.71%
2018 NZ$0.15 B69.32%
2017 NZ$90.69 M419.26%
2016 NZ$17.46 M-395.64%
2015 -NZ$5.91 Million-87.53%
2014 -NZ$47.4 Million-33.44%
2013 -NZ$71.21 Million
2011 -NZ$55.48 Million17.84%
2010 -NZ$47.09 Million35.5%
2009 -NZ$34.75 Million2.84%
2008 -NZ$33.79 Million60.81%
2007 -NZ$21.01 Million-52.14%
2006 -NZ$43.9 Million20.91%
2005 -NZ$36.31 Million31.87%
2004 -NZ$27.54 Million60.54%
2003 -NZ$17.15 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
NZ$44.57 B-316,146.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$27.08 B-192,119.46%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$18.17 B-128,944.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$53.40 B-378,749.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$22.56 B-160,100.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$16.46 B-116,851.82%๐Ÿ‡บ๐Ÿ‡ธ USA
MannKind Corp
MNKD
-NZ$49.04 Million 247.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
NZ$0.13 B-1,065.80%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
NZ$0.66 B-4,790.92%๐Ÿ‡บ๐Ÿ‡ธ USA